AZ is hoping that Fasenra (benralizumab) could join rival drugs from Sanofi/Regeneron and GlaxoSmithKline as approved therapies for chronic rhinosinusitis with nasal polyps (CRSwNP) that have been ...
Patients with unilateral chronic rhinosinusitis with nasal polyps (CRSwNP) tend to have less severe disease than those with bilateral nasal polyps and generally have better outcomes than those with ...
The role of the nasal microbiome in chronic rhinosinusitis (CRS) is generating increasing interest. A review article in the journal Pathogens details recent findings on the correlation between ...
Welcome to the Free Icons repository! This repository provides a collection of over 23,000 high-quality icons that you can use freely in your design projects. Whether you're working on web development ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback